BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Iijima K, Sekine H, Koike T, Imatani A, Ohara S, Shimosegawa T. Serum pepsinogen concentrations as a measure of gastric acid secretion in Helicobacter pylori-negative and -positive Japanese subjects. J Gastroenterol 2005;40:938-44. [PMID: 16261430 DOI: 10.1007/s00535-005-1677-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Ghosh T, Lewis DI, Axon ATR, Everett SM. Review article: methods of measuring gastric acid secretion: Review: methods of measuring gastric acid. Alimentary Pharmacology & Therapeutics 2011;33:768-81. [DOI: 10.1111/j.1365-2036.2010.04573.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
2 Oikawa T, Iijima K, Koike T, Uno K, Horii T, Iwai W, Abe Y, Asano N, Imatani A, Shimosegawa T. Deficient aldehyde dehydrogenase 2 is associated with increased risk for esophageal squamous cell carcinoma in the presence of gastric hypochlorhydria. Scandinavian Journal of Gastroenterology 2010;45:1338-44. [DOI: 10.3109/00365521.2010.495419] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
3 Iijima K, Koike T, Abe Y, Inomata Y, Sekine H, Imatani A, Nakaya N, Ohara S, Shimosegawa T. Extensive Gastric Atrophy: An Increased Risk Factor for Superficial Esophageal Squamous Cell Carcinoma in Japan. Am J Gastroenterology 2007;102:1603-9. [DOI: 10.1111/j.1572-0241.2007.01257.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
4 Cho JH, Jeon SR, Jin SY, Park S. Analysis of factors associated with recovery of the serum pepsinogen ratio after Helicobacter pylori eradication: a long-term follow-up study in Korea. Scand J Gastroenterol 2019;54:1306-14. [PMID: 31702966 DOI: 10.1080/00365521.2019.1686058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kim N, Jung HC. The role of serum pepsinogen in the detection of gastric cancer. Gut Liver. 2010;4:307-319. [PMID: 20981206 DOI: 10.5009/gnl.2010.4.3.307] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
6 Kim JH, Lee SY, Lee SP, Kim JH, Sung IK, Park HS, Shim CS, Han HS. The histologic detection of Helicobacter pylori in seropositive subjects is affected by pathology and secretory ability of the stomach. Helicobacter 2018;23:e12480. [PMID: 29520884 DOI: 10.1111/hel.12480] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Muhsen K, Pasetti MF, Reymann MK, Graham DY, Levine MM. Helicobacter pylori infection affects immune responses following vaccination of typhoid-naive U.S. adults with attenuated Salmonella typhi oral vaccine CVD 908-htrA. J Infect Dis. 2014;209:1452-1458. [PMID: 24273182 DOI: 10.1093/infdis/jit625] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
8 Lee S. Serum Assay Findings after Successful Helicobacter pylori Eradication. Korean J Helicobacter Up Gastrointest Res 2021;21:287-99. [DOI: 10.7704/kjhugr.2021.0031] [Reference Citation Analysis]
9 Iijima K, Koike T, Abe Y, Ara N, Uno K, Imatani A, Ohara S, Shimosegawa T. Alteration of correlation between serum pepsinogen concentrations and gastric acid secretion after H. pylori eradication. J Gastroenterol 2009;44:819-25. [DOI: 10.1007/s00535-009-0066-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
10 Lee SP, Lee SY, Kim JH, Sung IK, Park HS, Shim CS. Factors Related to Upper Gastrointestinal Symptom Generation in 2275 Helicobacter pylori Seroprevalent Adults. Dig Dis Sci 2017;62:1561-70. [PMID: 28281170 DOI: 10.1007/s10620-017-4529-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sakamoto Y, Oho K, Toyonaga A, Kumamoto M, Haruta T, Inoue H, Emori K, Tsuruta O, Sata M. Effect of Helicobacter pylori infection on esophagogastric variceal bleeding in patients with liver cirrhosis and portal hypertension. J Gastroenterol Hepatol. 2013;28:1444-1449. [PMID: 23577833 DOI: 10.1111/jgh.12221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
12 Coelho MCF, Ribeiro HG, Gomes CGO, Marinho FP, Barbosa AJA, Coelho LGV. HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE. Arq Gastroenterol 2021;58:39-47. [PMID: 33909795 DOI: 10.1590/S0004-2803.202100000-08] [Reference Citation Analysis]
13 Leja M, Linē A. Early detection of gastric cancer beyond endoscopy - new methods. Best Pract Res Clin Gastroenterol 2021;50-51:101731. [PMID: 33975677 DOI: 10.1016/j.bpg.2021.101731] [Reference Citation Analysis]
14 Elsebaey MA, Tawfik MA, Elshweikh SA, Negm MS, Elnaggar MH, Alghazaly GM, Abd-Elsalam S. Impact of Helicobacter pylori Infection on Gastric Variceal Bleeding among Patients with Liver Cirrhosis. Gastroenterol Res Pract 2019;2019:6529420. [PMID: 30881448 DOI: 10.1155/2019/6529420] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Abe Y, Iijima K, Koike T, Asanuma K, Imatani A, Ohara S, Shimosegawa T. Barrett's esophagus is characterized by the absence of Helicobacter pylori infection and high levels of serum pepsinogen I concentration in Japan. J Gastroenterol Hepatol 2009;24:129-34. [PMID: 19196398 DOI: 10.1111/j.1440-1746.2008.05691.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
16 Akyala AI, Peppelenbosch MP. Gastric cancer and Hedgehog signaling pathway: emerging new paradigms. Genes Cancer 2018;9:1-10. [PMID: 29725500 DOI: 10.18632/genesandcancer.168] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
17 Kim BC, Song MA, Kwon SH. Endoscopic Characteristics of Rugal Hyperplasia and Related Acid Condition in Helicobacter pylori-Infected Stomach. Clin Endosc 2021;54:73-84. [PMID: 33317224 DOI: 10.5946/ce.2020.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Miki K, Urita Y. Using serum pepsinogens wisely in a clinical practice. J Dig Dis. 2007;8:8-14. [PMID: 17261129 DOI: 10.1111/j.1443-9573.2007.00278.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 3.7] [Reference Citation Analysis]
19 Shimodaira Y, Onochi K, Watanabe K, Takahashi S, Fukuda S, Watanabe N, Koizumi S, Matsuhashi T, Iijima K. Effect of acid-reducing agents on clinical relapse in ulcerative colitis with pH-dependent-released 5-aminosalicylic acid: a multicenter retrospective study in Japan. Intest Res 2021;19:225-31. [PMID: 32806877 DOI: 10.5217/ir.2020.00023] [Reference Citation Analysis]
20 Coelho LGV, Marinho JR, Genta R, Ribeiro LT, Passos MDCF, Zaterka S, Assumpção PP, Barbosa AJA, Barbuti R, Braga LL, Breyer H, Carvalhaes A, Chinzon D, Cury M, Domingues G, Jorge JL, Maguilnik I, Marinho FP, Moraes-filho JPD, Parente JML, Paula-e-silva CMD, Pedrazzoli-júnior J, Ramos AFP, Seidler H, Spinelli JN, Zir JV. IVTH BRAZILIAN CONSENSUS CONFERENCE ON HELICOBACTER PYLORI INFECTION. Arq Gastroenterol 2018;55:97-121. [DOI: 10.1590/s0004-2803.201800000-20] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
21 Leja M, Camargo MC, Polaka I, Isajevs S, Liepniece-Karele I, Janciauskas D, Rudzite D, Kikuste I, Vanags A, Kojalo I, Folkmanis V, Kirsners A, Tolmanis I, Rabkin CS. Detection of gastric atrophy by circulating pepsinogens: A comparison of three assays. Helicobacter 2017;22. [PMID: 28557128 DOI: 10.1111/hel.12393] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
22 Iijima K, Koike T, Ara N, Nakagawa K, Kondo Y, Uno K, Hatta W, Asano N, Imatani A, Shimosegawa T. Identification of a high-risk group for low-dose aspirin-induced gastropathy by measuring serum pepsinogen in H. pylori-infected subjects. J Gastroenterol. 2015;50:305-312. [PMID: 24952898 DOI: 10.1007/s00535-014-0976-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
23 Iijima K, Shimosegawa T. Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury. World J Gastroenterol 2015; 21(25): 7709-7717 [PMID: 26167071 DOI: 10.3748/wjg.v21.i25.7709] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
24 Merchant JL, Ding L. Hedgehog Signaling Links Chronic Inflammation to Gastric Cancer Precursor Lesions. Cell Mol Gastroenterol Hepatol. 2017;3:201-210. [PMID: 28275687 DOI: 10.1016/j.jcmgh.2017.01.004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 7.4] [Reference Citation Analysis]
25 Shan J, Lei H, Shi W, Sun X, Tang Y, Ren C. High Serum Pepsinogen I and beta Helicobacter pylori Infection Are Risk Factors for Aspirin-Induced Gastroduodenal Injury. Dig Dis 2017;36:66-71. [DOI: 10.1159/000477203] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
26 Kim YJ, Paik CN, Jo IH, Kim DB, Lee JM. Serum Gastrin Predicts Hydrogen-Producing Small Intestinal Bacterial Overgrowth in Patients With Abdominal Surgery: A Prospective Study. Clin Transl Gastroenterol 2020;12:e00291. [PMID: 33369565 DOI: 10.14309/ctg.0000000000000291] [Reference Citation Analysis]